Outlook on the Cardiac Prosthetic Devices Global Market to 2025 - Players Include Abbott Laboratories, Biotronik & Boston Scientific Among Others

News provided by

Jul 21, 2020, 14:00 ET

DUBLIN, July 21, 2020 /PRNewswire/ -- The "Cardiac Prosthetic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The global cardiac prosthetic devices market is currently witnessing a healthy growth. Cardiac prosthetic devices refer to artificial devices that are implanted permanently or temporarily for repairing and replacing damaged heart tissues. Prosthetic heart valves, ventricular assist devices, pacemakers and annuloplasty rings are some of the commonly used cardiac prosthetic devices.

Heart valves, including mechanical, tissue (stented/stent-less) and transcatheter valves, are used to prevent retrograde blood flow and leakages. On the other hand, pacemakers are used for maintaining a stable heart rate using electrical impulses. These devices are configured to mimic the normal functioning of cardiovascular organs, and they also aid in preventing further blockages in the heart valves.

Owing to the sedentary lifestyles led by a majority of the population, coupled with their unhealthy dietary habits, there is an increasing prevalence of cardiovascular diseases (CVDs) and various heart ailments, such as cardiomyopathy and Coronary Artery Disease (CAD) across various regions. In line with this, the rising number of individuals with Marfan syndrome, which affects the heart and lungs, along with other vital organs in the body, is also contributing to the market growth. People with this inherited disease of connective tissues endure a damaged aorta and mitral valve prolapse, which may eventually require cardiac prosthetic device implantation as a treatment option for the effective working of the heart.

Furthermore, various technological advancements, such as the development of compact pacemakers and suture-less valve replacements, are acting as another growth-inducing factor. These devices are manufactured using durable and biocompatible raw materials and can be implanted into the patient's body through minimally invasive (MI) procedures. Other factors, including the growing geriatric population, improving healthcare infrastructure, rising awareness regarding the available treatment for CVDs and extensive research and development (R&D) activities, are projected to drive the market in the upcoming years. Looking forward, the publisher expects the market to grow at a CAGR of around 8% during 2020-2025.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Biotronik, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., Medtronic Inc., Meril Life Sciences Pvt. Ltd., Siemens Healthcare GmbH, Sorin Group, St. Jude Medical Inc., etc.

Key Questions Answered in this Report:

How has the global cardiac prosthetic devices market performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cardiac prosthetic devices market and who are the key players?
What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Cardiac Prosthetic Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast

6 Market Breakup by Product Type
6.1 Valves
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Mechanical Valve
6.1.2.2 Tissue Valve
6.1.2.3 Stented Tissue Valve
6.1.2.4 Stentless Tissue Valve
6.1.2.5 Transcatheter Valve
6.1.3 Market Forecast
6.2 Pacemakers
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Implantable Pacemakers
6.3.1 Market Trends
6.3.2 Major Types
6.3.2.1 Single-Chamber Battery Pacemaker
6.3.2.2 Dual-Chamber Battery Pacemaker
6.3.2.3 Triple-Chamber Battery Pacemaker
6.3.3 Market Forecast
6.4 External Pacemakers
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by End-User
7.1 Hospitals, Clinics and Cardiac Centers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Ambulatory Surgical Centers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast

9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2 Biotronik
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Boston Scientific Corporation
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Edwards Lifesciences Corporation
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 Lepu Medical Technology Co. Ltd.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Medtronic Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Meril Life Sciences Pvt. Ltd.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Siemens Healthcare GmbH
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 Sorin Group
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.10 St. Jude Medical Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio

For more information about this report visit https://www.researchandmarkets.com/r/f57s8a

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets